Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jacep.2024.07.005 | DOI Listing |
Publication Analysis
Top Keywords
reply glucagon-like
4
glucagon-like peptide-1
4
peptide-1 receptor
4
receptor agonists
4
agonists atrial
4
atrial fibrillation
4
fibrillation recurrence
4
recurrence ablation
4
ablation fire
4
fire smoke?
4
Similar Publications
Reply to the Letter to the Editor: Why Did the "Five-Year Incidence of Progression to Osteoarthritis and Total Joint Arthroplasty in Patients Prescribed Glucagon-Like Peptide 1 Receptor Agonists" Differ From the Previous Randomized Controlled Study?
J Arthroplasty
December 2024
Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.
Reply of the authors: a call for metabolic stratification within obesity research and an urgent need for human, reproductive translational research with glucagon-like peptide 1 receptor agonists.
Fertil Steril
January 2025
Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Reply to correspondence on "Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis".
Clin Mol Hepatol
October 2024
Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Reply: Glucagon-Like Peptide-1 Receptor Agonists and Atrial Fibrillation Recurrence After Ablation: A Fire Without the Smoke?
JACC Clin Electrophysiol
August 2024
Johns Hopkins School of Medicine, Baltimore, Maryland, USA. Electronic address:
Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists. Reply.
N Engl J Med
August 2024
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!